FLUIDIGM CORP (FLDM) Stock Price, Quote, News and Overview
NASDAQ:FLDM - Nasdaq - Common Stock
FLDM Quote, Performance and Key Statistics
3.71
-0.28 (-7.02%)
The current stock price of FLDM is 3.71 null. In the past month the price increased by 8.8%. In the past year, price decreased by -19.35%.
FLDM Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
| DHR | DANAHER CORP | 28.07 | 151.18B | ||
| A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
| IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
| WAT | WATERS CORP | 31.58 | 22.26B | ||
| ICLR | ICON PLC | 14.39 | 16.63B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
| ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
| RVTY | REVVITY INC | 23.23 | 13.85B | ||
| AVTR | AVANTOR INC | 17.3 | 11.78B | ||
| TEM | TEMPUS AI INC | N/A | 10.72B |
Related stock screener links
About FLDM
Company Profile
Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
Company Info
FLUIDIGM CORP
2 Tower Place, Suite 2000
South San Francisco CALIFORNIA 94080 US
CEO: Stephen Christopher Linthwaite
Employees: 615
Company Website: https://www.fluidigm.com/
Phone: 16502666000.0
FLUIDIGM CORP / FLDM FAQ
What is the stock price of FLUIDIGM CORP today?
The current stock price of FLDM is 3.71 null. The price decreased by -7.02% in the last trading session.
What is the ticker symbol for FLUIDIGM CORP stock?
The exchange symbol of FLUIDIGM CORP is FLDM and it is listed on the Nasdaq exchange.
On which exchange is FLDM stock listed?
FLDM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for FLUIDIGM CORP stock?
7 analysts have analysed FLDM and the average price target is 6.12 null. This implies a price increase of 64.96% is expected in the next year compared to the current price of 3.71. Check the FLUIDIGM CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is FLUIDIGM CORP worth?
FLUIDIGM CORP (FLDM) has a market capitalization of 285.37M null. This makes FLDM a Micro Cap stock.
How many employees does FLUIDIGM CORP have?
FLUIDIGM CORP (FLDM) currently has 615 employees.
What are the support and resistance levels for FLUIDIGM CORP (FLDM) stock?
FLUIDIGM CORP (FLDM) has a support level at 3.56 and a resistance level at 3.94. Check the full technical report for a detailed analysis of FLDM support and resistance levels.
Is FLUIDIGM CORP (FLDM) expected to grow?
The Revenue of FLUIDIGM CORP (FLDM) is expected to decline by -0.48% in the next year. Check the estimates tab for more information on the FLDM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy FLUIDIGM CORP (FLDM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FLDM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FLDM, evaluating the profitability, health, valuation and growth aspects
- FLUIDIGM CORP (FLDM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- FLUIDIGM CORP (FLDM) Sales and EPS estimates to see what analysts future expectations are.
- FLUIDIGM CORP (FLDM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- FLUIDIGM CORP (FLDM) Insider and Institutional Ownership to learn about the owners and their transactions.
- FLUIDIGM CORP (FLDM) Stock Chart to make your own analysis
- FLUIDIGM CORP (FLDM) Latest news and press-releases to stay up to date.
Does FLUIDIGM CORP (FLDM) stock pay dividends?
FLDM does not pay a dividend.
When does FLUIDIGM CORP (FLDM) report earnings?
FLUIDIGM CORP (FLDM) will report earnings on 2022-05-05, after the market close.
What is the Price/Earnings (PE) ratio of FLUIDIGM CORP (FLDM)?
FLUIDIGM CORP (FLDM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.78).
FLDM Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to FLDM. When comparing the yearly performance of all stocks, FLDM turns out to be only a medium performer in the overall market: it outperformed 66.04% of all stocks.
FLDM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to FLDM. Both the profitability and financial health of FLDM have multiple concerns.
FLDM Financial Highlights
Over the last trailing twelve months FLDM reported a non-GAAP Earnings per Share(EPS) of -0.78. The EPS decreased by -6.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -45.36% | ||
| ROA | -21.52% | ||
| ROE | N/A | ||
| Debt/Equity | 0.68 |
FLDM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to FLDM. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -30.77% and a revenue growth -0.48% for FLDM